Therefore, COVID-19 patients with CHD were four times more likely to die than average COVID-19 patients, with an elevated level of proinflammatory cytokines such as IL-6, CRP, and procoagulant factors such as D-Dimer20. This evidence concerns the gene IL6 and coronary artery disorder.